000 01502 a2200397 4500
005 20250515201437.0
264 0 _c20100607
008 201006s 0 0 eng d
022 _a1872-213X
024 7 _a10.2174/187221310789895603
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVenable, Jennifer D
245 0 0 _aPhosphoinositide 3-kinase gamma (PI3Kgamma) inhibitors for the treatment of inflammation and autoimmune disease.
_h[electronic resource]
260 _bRecent patents on inflammation & allergy drug discovery
_cJan 2010
300 _a1-15 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAutoimmune Diseases
_xdrug therapy
650 0 4 _aClass Ib Phosphatidylinositol 3-Kinase
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aHumans
650 0 4 _aInflammation
650 0 4 _aIsoenzymes
_xantagonists & inhibitors
650 0 4 _aPatents as Topic
650 0 4 _aPhosphoinositide-3 Kinase Inhibitors
650 0 4 _aSignal Transduction
650 0 4 _aStructure-Activity Relationship
650 0 4 _aSubstrate Specificity
650 0 4 _aThiazolidinediones
_xchemistry
700 1 _aAmeriks, Michael K
700 1 _aBlevitt, Jonathan M
700 1 _aThurmond, Robin L
700 1 _aFung-Leung, Wai-Ping
773 0 _tRecent patents on inflammation & allergy drug discovery
_gvol. 4
_gno. 1
_gp. 1-15
856 4 0 _uhttps://doi.org/10.2174/187221310789895603
_zAvailable from publisher's website
999 _c19398913
_d19398913